|The TGF-beta2 tgfb2 (Catalog #MBS843609) is a Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s TGF-beta2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB).
The peptide is used for blocking the antibody activity of TGF-beta2. It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30-60 minutes at 37 degree C. Researchers should empirically determine the suitability of the TGF-beta2 tgfb2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TGF-beta2 tgfb2 product has the following accession number(s) (GI #189053677) (NCBI Accession #BAG35929). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Handling: The peptide solution should be gently mixed before use. Bone, Brain, Connective Tissue, Embryonic Tissue, Eye, Heart, Lung, Muscle, Skin, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene. Breast Neoplasms, Cardiovascular Diseases, Disease Models, Animal, Fibrosis, Glaucoma, Heart Diseases, Inflammation, Kidney Diseases, Liver Diseases, Necrosis are some of the diseases may be linked to TGF-beta2 Blocking Peptide.